Results: 7

The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs

Biol. Res; 54 (), 2021
BACKGROUND: Breast cancer is the most frequently diagnosed cancer, and no effective treatment solution has yet been found. The number of studies based on the research of novel natural compounds in the treatment of breast cancer has been increasing in recent years. The anticancer properties of natural com...

Regression of macular edema with topical brinzolamide and nepafenac alone and identification of a novel gyrate atrophy mutation

Arq. bras. oftalmol; 83 (2), 2020
ABSTRACT Gyrate atrophy is a rare metabolic autosomal recessive disorder caused by ornithine aminotransferase enzyme deficiency that leads to characteristic progressive, degenerative chorioretinal findings. Patients complain mostly of low vision, night blindness, and peripheral vision loss. Posterior sub...

Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells

Arq. bras. oftalmol; 82 (1), 2019
ABSTRACT Purpose: To evaluate the effects of ranibizumab and amfenac in human uveal melanoma cell lines and to explore the ability of these compounds to sensitize uveal melanoma cells to radiation therapy. Methods: The 92.1 human uveal melanoma cell line was cultured and subjected to the proposed tre...

Analgesia preemptiva com nepafenaco 0, 1% na fotocoagulação da retina

Rev. bras. oftalmol; 73 (5), 2014
Objetivo: Avaliar o efeito preemptivo com nepafenaco 0,1% em pacientes submetidos à fotocoagulação da retina para tratamento da retinopatia diabética proliferativa. Métodos: Trinta pacientes foram submetidos à fotocoagulação com laser de argônio em ambos os olhos. O olho contralateral de cada pa...

Tratamento da hipertensão arterial com dose única diária de guanfacina
Treatment of arterial hypertension with a single daily dose of guanfacine

Arq. bras. cardiol; 43 (5), 1984
Foram estudados 52 pacientes portadores de hipertensao arterial leve ou moderada (pressao diastolica ate 115 mm Hg), com guanfacina, em dose unica. Em todos foi afastada disfuncao renal ou outra doenca concomitante. Apos 2 semanas de placebo, iniciou-se medicacao na dose de 0,5 mg por dia ao deitar, aume...